CALL FOR PROPOSALS

2021 HSCI MUSCULOSKELETAL DISEASE PROGRAM PILOT GRANTS

AWARD AMOUNT
Up to $100,000 for entire project period
Project period not to exceed two years
POSTED DATE
Friday, October 8, 2021
DEADLINE FOR APPLICATION
Friday, November 12, 2021
ANTICIPATED AWARD DATE
January 1, 2022
 

The Harvard Stem Cell Institute (HSCI) Musculoskeletal (MSK) Disease Program invites applications for pilot grant funding. The purpose of this program is to provide funding for innovative projects in the field of musculoskeletal stem cell and regenerative biology. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures for musculoskeletal injuries or disease. However, proposals at all stages of development are welcome, as are proposals that encompass a collaboration between two MSK labs where at least one of the labs is member of the HSCI. The HSCI MSK Program intends to award up to two grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI MSK Disease Program funds.... Read more about Call for Proposals: 2021 HSCI Musculoskeletal Disease Program Pilot Grants

A Harvard Stem Cell Institute (HSCI) led collaboration developed a new macroencapsulation device (MED) that protects the insulin-producing cells of the pancreas and enhances their survival with improved nutrient supply. ... Read more about Bioartificial device offers potential for treatment of Type 1 diabetes

Researchers at Massachusetts General Hospital (MGH) led by Harvard Stem Cell Institute Principal Faculty Harald C. Ott M.D. have generated the embryonic cells that support early heart development.

... Read more about Researchers generate protective embryonic heart cells

Harvard and Broad researchers combine single-cell genomic technologies to map the mouse cortex